OTC Hearing Aid and MCI
NCT: NCT06112860 · RECRUITING
Brief Summary
The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids: 1. improve communication 2. Whether the magnitude of benefit depends on the patient's level of cognitive disability, 3. Whether alternative remediation (such as targeted communication strategies) offer similar benefits. Participants and a communication partner will be randomized into an OTC first or Communication Strategies first arm, where participants will receive communication strategy information customized for those with cognitive impairment.
Frequently Asked Questions
What is OTC Hearing Aid and MCI?
OTC Hearing Aid and MCI is a clinical trial registered under NCT06112860. Current status: RECRUITING.
What is the status of NCT06112860?
The current status of NCT06112860 (OTC Hearing Aid and MCI) is: RECRUITING.
When did OTC Hearing Aid and MCI start?
OTC Hearing Aid and MCI started on 2024-07-23.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.